Prediction: Rigetti Stock Could Double Again in 2026

Rigetti Computing is advancing its quantum hardware with new chiplet-based architectures and improved hardware fidelity while expanding partnerships with government and industry, positioning the company closer to real-world quantum applications. The report notes potential meaningful upside if Rigetti can improve execution and fend off competition, but offers no financial metrics; market price context is provided (market prices as of Dec. 15, 2025) and the assessment was published Dec. 22, 2025.

Analysis

Market structure: Rigetti (RGTI) is a potential niche winner — chiplet architectures and higher fidelity can create a 2-5x improvement in usable qubit density versus monolithic designs over 2–4 years, benefiting quantum-software partners and cryogenics/equipment suppliers while keeping classical GPU leaders (NVDA) insulated near-term. Incumbent cloud/AI players lose little immediate revenue but face long-term margin pressure if quantum accelerates specialized workloads; government contractors stand to gain via procurement. Cross-asset: expect idiosyncratic equity volatility in RGTI (+/-30% near announcements), minimal sovereign FX impact, and negligible commodity effects other than modest copper/helium demand from expanded fabs.

Risk assessment: Tail risks include failed error-scaling (technical), a dilutive capital raise >$200M that erodes equity by >20%, or loss of key DOE/DoD contracts — each would be binary negatives within 3–12 months. Immediate (days) risk is headline volatility; short-term (3–12 months) is execution and cash runway; long-term (2–5 years) is commercial adoption and IP moat. Hidden dependencies: access to leading-node packaging fabs, specialized cryogenics supply chains, and talent retention; catalysts are public chiplet benchmarks, awarded contracts (> $5–10M), and cash-burn guidance.

Trade implications: Position size should be small and event-driven: a 1–2% portfolio speculative long in RGTI with downside protection, funded by trimming overweights in NVDA (take 3–5% profits if NVDA is >5% of portfolio). Option plays: buy 9–15 month call spreads or LEAPS if liquid, or buy stock + 6–12 month 30% OTM put. Sector rotation: shift 1–2% from broad AI hardware exposure into deep-tech/quantum tools and government-facing tech contractors.

Contrarian angles: Consensus underweights the probability of step-function revenue from a single large government contract — a >$10M award could re-rate RGTI quickly — but also underprices dilution risk and multi-year commercialization lag. Historical parallels: early GPU/ASIC cycles show long lead times (3–5 years) between lab fidelity and commercial revenue; mispricing often arises from binary outcomes, so asymmetric payoffs favor small, option-hedged stakes. Unintended consequence: headline-driven retail inflows could force volatility spikes and widen bid-ask spreads, increasing execution costs.

Key Decisions for Investors

• Establish a speculative 1–2% portfolio long in RGTI equity now; simultaneously buy a 6–12 month put ~30% OTM (or equivalent collar) to cap downside. Size to risk capital; reassess after next quarterly report.
• If options liquidity allows, execute a 9–15 month RGTI call spread (buy ATM LEAPS, sell a higher strike ~50% above ATM) sized at 0.5–1% portfolio to cost-effectively express binary upside tied to chiplet demos/contract awards.
• Trim NVDA exposure by 3–5% of total portfolio weight if NVDA position >5% — lock gains to fund RGTI exposure; sell into strength if NVDA advances another 15% from current levels.
• Monitor three near-term triggers over the next 6 months: (1) public chiplet performance benchmark (error rates/yield), (2) any government contract >$5–10M announced, and (3) cash runway reported >12 months; if none are met, reduce RGTI position to zero.